Navigation Links
Drugs to Treat Lung Damage in Preemies May Harm Brain
Date:11/17/2008

Even when given before birth, glucocorticoids tied to cognitive, motor control problems in mice

MONDAY, Nov. 17 (HealthDay News) -- Glucocorticoid drugs used to treat chronic lung damage in premature infants caused brain injury in mice and may cause cognitive and motor control problems even when they're given before birth, according to researchers at Washington University School of Medicine in St. Louis.

They examined the effects of the synthetic glucocorticoids dexamethasone and betamethasone, which are given to premature babies to aid lung development. The drugs caused brain cell death when given to mice four and 10 days after birth. The damage occurred in the cerebellum, the brain structure that controls movement and other functions.

"The cells that are damaged are called neural progenitor cells, which are responsible for producing new neurons. So you can imagine that if you kill the cells responsible for producing new neurons, you can cause severe neurodevelopmental effects," study first author Kevin K. Noguchi, a scientist in the department of psychiatry, said in a university news release.

That's what Noguchi and colleagues found when they examined adolescent mice that were given glucocorticoids during infancy. A single exposure to glucocorticoids permanently decreased the number of neurons in the cerebellum.

"The cerebellum connects to other brain structures, so when granule cells in the cerebellum are lost, you also have detrimental effects on cognitive function in non-motor regions of the brain. Other researchers have found IQ declines in children who have received these drugs early in life, and our findings may help explain why," senior investigator Dr. Nuri B. Farber, an associate professor of psychiatry, said in the news release.

If synthetic glucocorticoid drugs can be replaced with hormones made naturally in the body, it may be possible to avoid damage to brain cells while still promoting development of lungs in premature babies, the researchers said.

The study was expected to be presented Monday at the Society for Neuroscience annual meeting, in Washington, D.C.

In 2002, the American Academy of Pediatrics recommended a halt to post-natal glucocorticoid use unless used in clinical trials. However, it's still common practice to give the drugs to women at risk for preterm birth.

More information

The Nemours Foundation has more about premature babies.



-- Robert Preidt



SOURCE: Washington University School of Medicine in St. Louis, news release, Nov. 17, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. drugstore.com Offers Free Shipping to U.S. Troops Serving Overseas and in the United States
2. Kevin P. Miller's Film "Generation RX" Reveals Widespread Ethical Conflicts, Risks of Psychiatric Drugs to Children
3. Cancer drugs my build and not tear down blood vessels
4. drugstore.com inc. Reports Solid Revenue Growth and Record Gross Margins in the Third Quarter of 2008
5. When It Comes to Prescription Drugs, Get Smart
6. China Nepstar Chain Drugstore to Announce Third Quarter 2008 Financial Results on November 26
7. Medicaid policies vary widely for rheumatoid arthritis drugs
8. Tweens and Teens Double Use of Diabetes Drugs
9. Anti-VEGF drugs for retinal diseases could have serious side effects, scientists caution
10. Anti-VEGF Drugs for Retinal Diseases Could Have Serious Side Effects, Scientists Caution
11. Tweens and teens double use of diabetes drugs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drugs to Treat Lung Damage in Preemies May Harm Brain
(Date:6/26/2016)... ... June 26, 2016 , ... ... they have been diagnosed with endometriosis. These women need a treatment plan to ... a comprehensive approach that can help for preservation of fertility and ultimately achieving ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg ... Legal Elite. The attorneys chosen by their peers for this recognition are considered among ... Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite Hall ...
(Date:6/24/2016)... ... 2016 , ... EB Medicine presented its first-ever “Issue of ... in Ponte Vedra Beach, FL. The awards honor the outstanding work of leading ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the efforts ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
Breaking Medicine Technology: